What did Workspace's board say about Saba Capital's revised proposals?

Workspace's board publicly dismissed Saba Capital's revised proposals as a "stealth managed wind-down", said the plan would risk forcing asset sales in a slow/weak market, and urged shareholders to vote against Saba at the AGM.

Workspace — TickStock

Timeline

Workspace board rejects Saba disposal strategy as forced-seller risk

07:47, 9 Jul 2026 · Updated 16:59, 9 Jul

Workspace Group targets £125m trading profit as it pivots to earnings

08:05, 10 Jun 2026

Workspace warns of profit hit as new CEO repositions business

08:59, 17 Apr 2026

More in Pharma

A laboratory technician is performing an analysis in a lab setting, wearing protective gear and using pipettes. The workspace features various laboratory equipment and samples, emphasizing a research environment.

Pharma

Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer

Positive overall survival data from a China trial of risvutatug rezetecan marks the first Phase III success for any B7-H3-targeted antibody-drug conjugate, strengthening GSK's broader development programme.

Updated 14:01, 10 Jul 2026

Biotech

Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew

17:02, 9 Jul 2026

Pharma

AstraZeneca and Ionis ATTR-CM trial fails primary endpoint

07:36, 9 Jul 2026

Pharma

OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design

13:39, 8 Jul 2026

Biotech

Physiomics wins contracts across two service lines

10:21, 8 Jul 2026

Real Estate & REITs

Segro doubles new rent secured in first half as development pipeline hits record

09:55, 8 Jul 2026

Biotech

Coiled Therapeutics advances softgel formulation ahead of dose expansion

10:42, 7 Jul 2026

Medtech & Diagnostics

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

07:53, 3 Jul 2026

Oil & Gas

The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika

07:51, 3 Jul 2026

Biotech

PureTech spins out Celea Therapeutics with $180m Raise

11:32, 2 Jul 2026

Real Estate & REITs

Supermarket Income REIT completes £445m debt refinancing at lower margin

08:34, 2 Jul 2026

Workspace Group plc is a UK-listed real estate company that owns and operates flexible workspace properties, primarily servicing small and medium-sized enterprises across London and other major UK cities. The company generates revenue through property leasing and related services, positioning itself as a provider of agile office solutions in the competitive UK commercial real estate market. As a mid-cap REIT, Workspace Group operates a diversified portfolio of workspace assets with exposure to London's central and outer zones.

Sector: Pharma
Market: MAINMARKET

Insight

What rating and price target did Panmure Liberum give Workspace on 9 July 2026?

On 9 July 2026 Panmure Liberum reiterated a Hold rating on Workspace and set a 450p price target.

Updated 9 Jul 2026

Insight

How many businesses does Workspace house across its portfolio?

Workspace houses approximately 4,000 businesses across its portfolio.

Updated 9 Jul 2026

Insight

Where is Workspace's asset base concentrated?

Workspace's asset base is concentrated in the UK, notably in London, concentrating market and demand risk in a single national market and within London sub-markets.

Updated 10 Jun 2026

Insight

How many properties did Workspace sell in the year to March 2026 and at what average discount to most recent book value?

Workspace sold 13 properties in the year to March 2026 at an average 7.2% discount to most recent book value (around a 19.6% discount versus valuations six months earlier).

Updated 9 Jul 2026

Insight

What type of company is Workspace?

Workspace is a mid-cap real estate investment trust (REIT).

Updated 10 Jun 2026

Identifiers

Ticker: WKP
Market: MAINMARKET
ISIN: GB00B67G5X01
LEI: 2138003GUZRFIN3UT430

Learn more on:

GLEIF Companies House

Timeline

Workspace board rejects Saba disposal strategy as forced-seller risk

Workspace Group targets £125m trading profit as it pivots to earnings

Workspace warns of profit hit as new CEO repositions business

More in Pharma

Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer

Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew

AstraZeneca and Ionis ATTR-CM trial fails primary endpoint

OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design

Physiomics wins contracts across two service lines

Segro doubles new rent secured in first half as development pipeline hits record

Coiled Therapeutics advances softgel formulation ahead of dose expansion

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika

PureTech spins out Celea Therapeutics with $180m Raise

Supermarket Income REIT completes £445m debt refinancing at lower margin

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer